Cytosorbents CorporationCTSONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-18.0%
5Y CAGR-32.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-18.0%/yr
vs -36.9%/yr prior
5Y CAGR
-32.8%/yr
Recent acceleration
Acceleration
+18.9pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.07 | -22.9% |
| 2024 | 1.39 | -12.7% |
| 2023 | 1.59 | -18.1% |
| 2022 | 1.95 | -57.0% |
| 2021 | 4.53 | -42.2% |
| 2020 | 7.84 | +43.8% |
| 2019 | 5.45 | -55.5% |
| 2018 | 12.26 | -8.6% |
| 2017 | 13.41 | -20.6% |
| 2016 | 16.89 | - |